31/08/2020
Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss limited to 0.1 million euros.... more
28/07/2020
Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss and Q2 operating loss limited to 0.1 million euros. Half-year EBITDA at 0.5 million euros and Q2 EBITDA at 0.2 million euros despite an unprecedented macroeconomic environment. Increase of available liquidities up to EUR 4.2 million at 30 June 2020.... more
30/04/2020
(French version only)... more
27/04/2020
Significant sales growth despite a deteriorated macroeconomic environment. Net and operating earnings at the break-even point. Positive EBITDA at EUR 0.3 million.... more
23/03/2020
Consolidated revenue at EUR 12.8 million for FY 19. Avionics business up +9% for FY 19. Operating profit at EUR 0.1 million – Net earnings at the break-even point. Consolidated available cash at EUR 3.4 million as of December 31, 2019.... more
23/01/2020
Significant sales recovery for the optical communications business vs Q3 19. Quarterly consolidated sales at 3.2 million euros vs 3.1 million euros in Q4 18. Q4 19 operating and net earnings at the break-even point. Positive quarterly EBITDA at +0.3 million euros leading to cumulative 12-month EBITDA at +1.5 million euros.... more
European Headquarters:
MEMSCAP S.A.
Parc Activillage des Fontaines
ZI Bernin
38 926 Crolles Cedex
France
Phone : +33 (0)4 76 92 85 00
Fax : +33 (0)4 76 92 85 01
Access map: click here
upcoming events:
